Wall Street analysts expect Imperva Inc (NASDAQ:IMPV) to report earnings per share of $0.14 for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Imperva’s earnings. The highest EPS estimate is $0.15 and the lowest is $0.13. Imperva posted earnings of $0.33 per share in the same quarter last year, which would suggest a negative year over year growth rate of 57.6%. The business is scheduled to announce its next earnings report on Wednesday, November 14th.

According to Zacks, analysts expect that Imperva will report full year earnings of $0.33 per share for the current fiscal year, with EPS estimates ranging from $0.25 to $0.91. For the next fiscal year, analysts anticipate that the company will post earnings of $1.00 per share, with EPS estimates ranging from $0.79 to $1.70. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that cover Imperva.

Imperva (NASDAQ:IMPV) last released its quarterly earnings data on Thursday, July 26th. The software maker reported ($0.26) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.33) by $0.07. The firm had revenue of $84.80 million for the quarter, compared to the consensus estimate of $87.22 million. Imperva had a negative return on equity of 6.92% and a negative net margin of 8.59%. The company’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.24 earnings per share.

Several analysts recently issued reports on the company. Zacks Investment Research cut Imperva from a “hold” rating to a “sell” rating in a research note on Friday, August 3rd. DA Davidson cut Imperva from a “buy” rating to a “neutral” rating and cut their target price for the stock from $56.00 to $46.00 in a research note on Friday, July 27th. Oppenheimer cut Imperva from an “outperform” rating to a “market perform” rating and set a $70.00 target price on the stock. in a research note on Friday, July 27th. Stephens raised their target price on Imperva from $61.00 to $67.00 and gave the stock an “overweight” rating in a research note on Thursday, June 14th. Finally, ValuEngine raised Imperva from a “sell” rating to a “hold” rating in a research note on Saturday, June 2nd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the company. The company has an average rating of “Hold” and an average target price of $54.00.

Shares of NASDAQ IMPV traded up $0.50 during trading hours on Friday, hitting $47.15. The company’s stock had a trading volume of 13,505 shares, compared to its average volume of 324,607. The stock has a market capitalization of $1.63 billion, a PE ratio of -168.57 and a beta of 1.68. Imperva has a 12 month low of $37.17 and a 12 month high of $57.65.

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. boosted its position in Imperva by 4.0% during the 2nd quarter. BlackRock Inc. now owns 2,362,641 shares of the software maker’s stock valued at $113,997,000 after acquiring an additional 91,444 shares in the last quarter. RGM Capital LLC boosted its position in Imperva by 0.8% during the 2nd quarter. RGM Capital LLC now owns 1,777,212 shares of the software maker’s stock valued at $85,750,000 after acquiring an additional 14,045 shares in the last quarter. Rothschild Asset Management Inc. boosted its position in Imperva by 18.4% during the 2nd quarter. Rothschild Asset Management Inc. now owns 594,441 shares of the software maker’s stock valued at $28,682,000 after acquiring an additional 92,349 shares in the last quarter. Bank of America Corp DE boosted its position in Imperva by 1.2% during the 2nd quarter. Bank of America Corp DE now owns 528,022 shares of the software maker’s stock valued at $25,478,000 after acquiring an additional 6,443 shares in the last quarter. Finally, Legal & General Group Plc boosted its position in Imperva by 27.9% during the 2nd quarter. Legal & General Group Plc now owns 519,725 shares of the software maker’s stock valued at $25,077,000 after acquiring an additional 113,280 shares in the last quarter.

Imperva Company Profile

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Recommended Story: What kind of dividend yield to CEF’s pay?

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.